Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Clinical & Translational Immunology|December 15, 2025
Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitisLisa Denny, Katharina Robichon, Nikki Templeton, et al.
Clinical & Translational Immunology|December 13, 2023
Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune-driven demyelinationKatharina Robichon, Rabia Bibi, Mackenzie Kiernan, et al.
Clinical & Translational Immunology|January 25, 2021
Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating diseaseLisa Denny, Afnan Al Abadey, Katharina Robichon, et al.
Frontiers in Neuroscience|August 15, 2020
Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of PainKelly F Paton, Andrew Biggerstaff, Sophia Kaska, et al.
Basic & Clinical Pharmacology & Toxicology|December 18, 2025
Development and Application of an LC-MS Method for the Pharmacokinetics and Pharmacodynamics of Oral Therapeutic Efficacy of NalfurafineSven Sondhauss, Mackenzie Kiernan, Julia Morizzi, et al.
Journal of Medicinal Chemistry|April 5, 2017
Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic StabilityAlexander M Sherwood, Rachel Saylor Crowley, Kelly F Paton, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2025
Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinolRoss van de Wetering, Amy F Alder, Andrew Biggerstaff, et al.
Frontiers in Neurology|January 6, 2022
The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple SclerosisKelly F Paton, Katharina Robichon, Nikki Templeton, et al.
Pageof 4